ELV reaffirms 2026 EPS guidance; targets 12%+ 2027 growth
Management reaffirmed 2026 EPS guidance and expects at least 12% EPS growth in 2027. The company attributes the outlook to execution, favorable cost trends, disciplined investments in AI and Carelon, and strong performance across Medicare Advantage, Medicaid, and ACA segments.